Isoproterenol Hydrochloride NDC 55150-317

NDC codes

FDA NDC Directory

Product NDC (as listed)55150-317Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55150-0317Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55150-317-10	55150031710	10 AMPULE in 1 CARTON (55150-317-10) / 5 mL in 1 AMPULE (55150-317-01)Marketed from Feb 9, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Isoproterenol Hydrochloride
Generic name (nonproprietary): isoproterenol hydrochloride
Active ingredients: Isoproterenol hydrochloride — 1 mg/5mL
Dosage form: Injection, Solution
Route: Intracardiac, Intramuscular, Intravenous, Subcutaneous
Labeler: Eugia US LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211864
Marketing start: Feb 9, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Agonists (Mechanism)
Identifiers: Product ID 55150-317_a2c8dee4-69b8-479b-a203-25fdd0c234f1SPL ID a2c8dee4-69b8-479b-a203-25fdd0c234f1SPL set ID 3e4050e8-7d94-4ed7-951d-1ff818ddadf1RxCUI 1667909, 1667915UNII DIA2A74855UPC 0355150317011, 0355150317103
Pharmacologic class: beta-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455150031710 followed by a unit qualifier and the quantity

Package 55150-0317-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 16, 2025.

Indications (excerpt from the label)

Isoproterenol hydrochloride injection is indicated: To improve hemodynamic status in patients in distributive shock and shock due to reduced cardiac output For bronchospasm occurring during anesthesia Isoproterenol hydrochloride injection is a beta-adrenergic agonist indicated: To improve hemodynamic status in patients in distributive shock and shock due to reduced cardiac output ( 1 ) For treatment of bronchospasm occurring during anesthesia ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211864

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211864
Product	Strength	Form · route	Labeler	Product NDC
Isoproterenol Hydrochloride	Isoproterenol hydrochloride .2 mg/mL	Injection, SolutionIntracardiac, Intramuscular, Intravenous, Subcutaneous	Eugia US LLC	55150-316